

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.43235926 |
| 2 | microglial cell activation (GO:0001774) | 5.88330444 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.72844631 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 5.47403897 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.46232325 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.46232325 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.46232325 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.46232325 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.46232325 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.46232325 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.95848515 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.95848515 |
| 13 | hepatocyte apoptotic process (GO:0097284) | 4.93548521 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.89141050 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.80025290 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.79646681 |
| 17 | macrophage activation (GO:0042116) | 4.55720820 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.53578487 |
| 19 | cellular extravasation (GO:0045123) | 4.43902055 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.41227628 |
| 21 | histone H3-K36 demethylation (GO:0070544) | 4.27479724 |
| 22 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.24003024 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 4.21712219 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.14513906 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.00737125 |
| 26 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.94575819 |
| 27 | response to interleukin-15 (GO:0070672) | 3.88925039 |
| 28 | negative T cell selection (GO:0043383) | 3.88329041 |
| 29 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.87016173 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.86400918 |
| 31 | response to host immune response (GO:0052572) | 3.86400918 |
| 32 | negative thymic T cell selection (GO:0045060) | 3.85169111 |
| 33 | positive T cell selection (GO:0043368) | 3.84226926 |
| 34 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.83322760 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.80350397 |
| 36 | negative regulation of B cell proliferation (GO:0030889) | 3.70871586 |
| 37 | positive regulation of granulocyte differentiation (GO:0030854) | 3.68554075 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.67365453 |
| 39 | interferon-gamma production (GO:0032609) | 3.67316223 |
| 40 | cellular response to interleukin-15 (GO:0071350) | 3.66405123 |
| 41 | neutrophil mediated immunity (GO:0002446) | 3.62843324 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.62408686 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.62250846 |
| 44 | response to host (GO:0075136) | 3.62250846 |
| 45 | response to host defenses (GO:0052200) | 3.62250846 |
| 46 | histone mRNA catabolic process (GO:0071044) | 3.61136856 |
| 47 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.58284057 |
| 48 | myeloid leukocyte mediated immunity (GO:0002444) | 3.57246684 |
| 49 | activated T cell proliferation (GO:0050798) | 3.53485327 |
| 50 | positive thymic T cell selection (GO:0045059) | 3.52800434 |
| 51 | protein K11-linked deubiquitination (GO:0035871) | 3.51773202 |
| 52 | establishment of protein localization to Golgi (GO:0072600) | 3.48705942 |
| 53 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.45111699 |
| 54 | positive regulation of B cell differentiation (GO:0045579) | 3.42330047 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 3.38520925 |
| 56 | cellular response to ethanol (GO:0071361) | 3.37119550 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 3.35721341 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.33825712 |
| 59 | protein targeting to Golgi (GO:0000042) | 3.33463642 |
| 60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.33383117 |
| 61 | detection of biotic stimulus (GO:0009595) | 3.28035330 |
| 62 | detection of other organism (GO:0098543) | 3.27559474 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 3.18709301 |
| 64 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.15348776 |
| 65 | regulation of necroptotic process (GO:0060544) | 3.11825475 |
| 66 | T cell migration (GO:0072678) | 3.07857553 |
| 67 | positive regulation of interferon-alpha production (GO:0032727) | 3.04848214 |
| 68 | respiratory burst (GO:0045730) | 3.04223711 |
| 69 | protein K48-linked deubiquitination (GO:0071108) | 3.02051792 |
| 70 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.01088210 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.96515317 |
| 72 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.94687635 |
| 73 | positive regulation of mast cell activation (GO:0033005) | 2.94622939 |
| 74 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.93254352 |
| 75 | T cell selection (GO:0045058) | 2.93158753 |
| 76 | regulation of beta-amyloid formation (GO:1902003) | 2.92797447 |
| 77 | dosage compensation (GO:0007549) | 2.90591216 |
| 78 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.87452462 |
| 79 | regulation of platelet aggregation (GO:0090330) | 2.83250059 |
| 80 | leukocyte aggregation (GO:0070486) | 2.82090631 |
| 81 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.80855981 |
| 82 | negative regulation of B cell mediated immunity (GO:0002713) | 2.80550157 |
| 83 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.80550157 |
| 84 | histone H3-K4 trimethylation (GO:0080182) | 2.80336815 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.80202418 |
| 86 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79873184 |
| 87 | T cell proliferation (GO:0042098) | 2.78471084 |
| 88 | regulation of interferon-alpha production (GO:0032647) | 2.78274073 |
| 89 | negative regulation of adaptive immune response (GO:0002820) | 2.76716726 |
| 90 | regulation of granulocyte differentiation (GO:0030852) | 2.76173466 |
| 91 | regulation of mast cell activation (GO:0033003) | 2.75573546 |
| 92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.74397332 |
| 93 | neutrophil activation (GO:0042119) | 2.71930471 |
| 94 | regulation of B cell proliferation (GO:0030888) | 2.70048049 |
| 95 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.66902098 |
| 96 | T-helper 1 type immune response (GO:0042088) | 2.65699817 |
| 97 | response to peptidoglycan (GO:0032494) | 2.65197576 |
| 98 | defense response to protozoan (GO:0042832) | 2.64925311 |
| 99 | regulation of mast cell degranulation (GO:0043304) | 2.64256501 |
| 100 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.63833950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.79431116 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.73057852 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.22497111 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.43310033 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.37540192 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.29447776 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.18253149 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.12799153 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.10021034 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.04060073 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92525305 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.77906222 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75957017 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.74751388 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73291513 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.52283904 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.50107954 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.44057091 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.38003863 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.37121144 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12772715 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.92798091 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87071939 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.87014609 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 1.86926751 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.80917822 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80657371 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.80165972 |
| 29 | TP53_16413492_ChIP-PET_HCT116_Human | 1.73901699 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66023750 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64459807 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59778292 |
| 33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57151648 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55995547 |
| 35 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53252180 |
| 36 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.48909247 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47466525 |
| 38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45801920 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40407934 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.39702856 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38000502 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35378745 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32923817 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.32577934 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32035799 |
| 46 | GATA2_19941826_ChIP-Seq_K562_Human | 1.30953956 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27895634 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27576416 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26363720 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26132738 |
| 51 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.25757462 |
| 52 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23249002 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20514024 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18491589 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18482785 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18417893 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10560981 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10056861 |
| 59 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09708895 |
| 60 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.08814310 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08526314 |
| 62 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.07391916 |
| 63 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03907537 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03354714 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00005111 |
| 66 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99492020 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99210736 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98435199 |
| 69 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98326950 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95848845 |
| 71 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95052745 |
| 72 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95052745 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93295176 |
| 74 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.92070857 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91962233 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90804393 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89286213 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88884812 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87825107 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87225796 |
| 81 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87019343 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86816403 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86629788 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86430465 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86380529 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86378673 |
| 87 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.85100652 |
| 88 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.84592451 |
| 89 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84142130 |
| 90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.83406006 |
| 91 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82551479 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82236102 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82175881 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82118640 |
| 95 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.81373176 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80499240 |
| 97 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.79445034 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.78707109 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.77216295 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.76808680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.85449879 |
| 2 | MP0003724_increased_susceptibility_to | 3.90505437 |
| 3 | MP0008260_abnormal_autophagy | 3.55736280 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.29318024 |
| 5 | MP0008057_abnormal_DNA_replication | 3.01018101 |
| 6 | MP0003183_abnormal_peptide_metabolism | 2.92158820 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.91498852 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.81741492 |
| 9 | MP0003303_peritoneal_inflammation | 2.65050397 |
| 10 | MP0001800_abnormal_humoral_immune | 2.60845731 |
| 11 | MP0003787_abnormal_imprinting | 2.33390987 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.33389621 |
| 13 | MP0005451_abnormal_body_composition | 2.18211614 |
| 14 | MP0002419_abnormal_innate_immunity | 2.17823971 |
| 15 | MP0004381_abnormal_hair_follicle | 2.16794786 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.14991972 |
| 17 | MP0004883_abnormal_blood_vessel | 2.14074029 |
| 18 | MP0003436_decreased_susceptibility_to | 2.12805573 |
| 19 | MP0002723_abnormal_immune_serum | 2.12321723 |
| 20 | MP0005671_abnormal_response_to | 2.09739371 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.04643867 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.04446071 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.04216598 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.02903900 |
| 25 | MP0001819_abnormal_immune_cell | 2.01301380 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.94834099 |
| 27 | MP0000015_abnormal_ear_pigmentation | 1.92945421 |
| 28 | MP0000685_abnormal_immune_system | 1.89230450 |
| 29 | MP0002398_abnormal_bone_marrow | 1.87161878 |
| 30 | MP0005025_abnormal_response_to | 1.82024515 |
| 31 | MP0005310_abnormal_salivary_gland | 1.80557845 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.78468140 |
| 33 | MP0003828_pulmonary_edema | 1.76104914 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.74532120 |
| 35 | MP0000716_abnormal_immune_system | 1.71526595 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.67902999 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.67852535 |
| 38 | MP0002009_preneoplasia | 1.67288667 |
| 39 | MP0003221_abnormal_cardiomyocyte_apopto | 1.66857332 |
| 40 | MP0002405_respiratory_system_inflammati | 1.66418523 |
| 41 | MP0003690_abnormal_glial_cell | 1.62614558 |
| 42 | MP0005387_immune_system_phenotype | 1.60698356 |
| 43 | MP0001790_abnormal_immune_system | 1.60698356 |
| 44 | MP0002722_abnormal_immune_system | 1.59135425 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.58826359 |
| 46 | MP0009785_altered_susceptibility_to | 1.55058731 |
| 47 | MP0002006_tumorigenesis | 1.54282364 |
| 48 | MP0006082_CNS_inflammation | 1.51943383 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.51354431 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.51105565 |
| 51 | MP0005164_abnormal_response_to | 1.41253072 |
| 52 | MP0004484_altered_response_of | 1.35258865 |
| 53 | MP0001851_eye_inflammation | 1.33982751 |
| 54 | MP0002429_abnormal_blood_cell | 1.32817446 |
| 55 | MP0003866_abnormal_defecation | 1.29729975 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.26548668 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.24634274 |
| 58 | MP0002163_abnormal_gland_morphology | 1.17054207 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.12578775 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.12578775 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.10697116 |
| 62 | MP0009764_decreased_sensitivity_to | 1.10616210 |
| 63 | MP0004130_abnormal_muscle_cell | 1.09380111 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.07287911 |
| 65 | MP0000604_amyloidosis | 1.05131346 |
| 66 | MP0004947_skin_inflammation | 1.03660470 |
| 67 | MP0000858_altered_metastatic_potential | 1.02924098 |
| 68 | MP0000371_diluted_coat_color | 0.98940478 |
| 69 | MP0001853_heart_inflammation | 0.98480776 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.97553735 |
| 71 | MP0005076_abnormal_cell_differentiation | 0.95922487 |
| 72 | MP0003091_abnormal_cell_migration | 0.94314353 |
| 73 | MP0005376_homeostasis/metabolism_phenot | 0.92184735 |
| 74 | MP0002132_abnormal_respiratory_system | 0.91411405 |
| 75 | MP0010155_abnormal_intestine_physiology | 0.90601177 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.86925911 |
| 77 | MP0003191_abnormal_cellular_cholesterol | 0.81822954 |
| 78 | MP0006054_spinal_hemorrhage | 0.81033180 |
| 79 | MP0008469_abnormal_protein_level | 0.80941303 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 0.77876759 |
| 81 | MP0009115_abnormal_fat_cell | 0.77589930 |
| 82 | MP0005266_abnormal_metabolism | 0.77153060 |
| 83 | MP0003121_genomic_imprinting | 0.74385265 |
| 84 | MP0003329_amyloid_beta_deposits | 0.74379513 |
| 85 | MP0000249_abnormal_blood_vessel | 0.74050423 |
| 86 | MP0003632_abnormal_nervous_system | 0.71253403 |
| 87 | MP0003045_fibrosis | 0.69301947 |
| 88 | MP0009278_abnormal_bone_marrow | 0.69259522 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.65825855 |
| 90 | MP0005408_hypopigmentation | 0.65789177 |
| 91 | MP0001915_intracranial_hemorrhage | 0.64910523 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.64876807 |
| 93 | MP0003195_calcinosis | 0.64765815 |
| 94 | MP0005379_endocrine/exocrine_gland_phen | 0.64531274 |
| 95 | MP0002928_abnormal_bile_duct | 0.63571420 |
| 96 | MP0003448_altered_tumor_morphology | 0.62970370 |
| 97 | MP0005388_respiratory_system_phenotype | 0.61836292 |
| 98 | MP0002133_abnormal_respiratory_system | 0.61836292 |
| 99 | MP0005621_abnormal_cell_physiology | 0.61150653 |
| 100 | MP0000427_abnormal_hair_cycle | 0.60569505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.67433114 |
| 2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 5.55008567 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.50714037 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.16169103 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.66400165 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.15890596 |
| 7 | Optic neuritis (HP:0100653) | 4.15890596 |
| 8 | Spontaneous hematomas (HP:0007420) | 3.95822752 |
| 9 | Orchitis (HP:0100796) | 3.95192659 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.94656853 |
| 11 | Myositis (HP:0100614) | 3.83361935 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.79183664 |
| 13 | Slow saccadic eye movements (HP:0000514) | 3.68738216 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.66777435 |
| 15 | Recurrent skin infections (HP:0001581) | 3.51748183 |
| 16 | Gingival bleeding (HP:0000225) | 3.40105377 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.32346355 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.32346355 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.30523580 |
| 20 | Abnormality of T cells (HP:0002843) | 3.28332307 |
| 21 | Arterial thrombosis (HP:0004420) | 3.10080103 |
| 22 | Gingivitis (HP:0000230) | 3.01833765 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 2.99544418 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98656593 |
| 25 | Recurrent viral infections (HP:0004429) | 2.98081757 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 2.81325295 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.81106728 |
| 28 | Genetic anticipation (HP:0003743) | 2.79287594 |
| 29 | Encephalitis (HP:0002383) | 2.78747368 |
| 30 | Thoracolumbar scoliosis (HP:0002944) | 2.78326174 |
| 31 | Subacute progressive viral hepatitis (HP:0006572) | 2.77455887 |
| 32 | Leukocytosis (HP:0001974) | 2.76180005 |
| 33 | Keratoconjunctivitis (HP:0001096) | 2.73773128 |
| 34 | Peritonitis (HP:0002586) | 2.70738339 |
| 35 | Chest pain (HP:0100749) | 2.69751580 |
| 36 | Postural instability (HP:0002172) | 2.69715623 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69056071 |
| 38 | Stomatitis (HP:0010280) | 2.67700132 |
| 39 | Conjunctival telangiectasia (HP:0000524) | 2.67253897 |
| 40 | Broad ribs (HP:0000885) | 2.67131417 |
| 41 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.58439454 |
| 42 | Meningitis (HP:0001287) | 2.54860603 |
| 43 | Papillary thyroid carcinoma (HP:0002895) | 2.54434889 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.53864673 |
| 45 | Vasculitis (HP:0002633) | 2.52779389 |
| 46 | Diastasis recti (HP:0001540) | 2.49047392 |
| 47 | Epistaxis (HP:0000421) | 2.43025970 |
| 48 | Hemoptysis (HP:0002105) | 2.40469837 |
| 49 | Eosinophilia (HP:0001880) | 2.37069131 |
| 50 | Abnormality of eosinophils (HP:0001879) | 2.35725726 |
| 51 | Subaortic stenosis (HP:0001682) | 2.26702255 |
| 52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.26702255 |
| 53 | Vertebral arch anomaly (HP:0008438) | 2.25945262 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.25541560 |
| 55 | Viral hepatitis (HP:0006562) | 2.25299965 |
| 56 | Visual hallucinations (HP:0002367) | 2.24704612 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.23735277 |
| 58 | Periodontitis (HP:0000704) | 2.23107580 |
| 59 | Anorexia (HP:0002039) | 2.20188908 |
| 60 | Thyroiditis (HP:0100646) | 2.20021959 |
| 61 | Amaurosis fugax (HP:0100576) | 2.17149553 |
| 62 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.14535111 |
| 63 | Poikilocytosis (HP:0004447) | 2.13983237 |
| 64 | Pulmonary embolism (HP:0002204) | 2.10599109 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.09062149 |
| 66 | Hypoplasia of the thymus (HP:0000778) | 2.08306508 |
| 67 | IgA deficiency (HP:0002720) | 2.07636247 |
| 68 | Bladder carcinoma (HP:0002862) | 2.04818922 |
| 69 | Bladder neoplasm (HP:0009725) | 2.04818922 |
| 70 | Obstructive lung disease (HP:0006536) | 2.04481818 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04481818 |
| 72 | Resting tremor (HP:0002322) | 2.00859130 |
| 73 | Pustule (HP:0200039) | 2.00790220 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.00776386 |
| 75 | Carpal bone hypoplasia (HP:0001498) | 2.00573426 |
| 76 | Microcytic anemia (HP:0001935) | 1.99300673 |
| 77 | Hemiplegia (HP:0002301) | 1.99131188 |
| 78 | Granulocytopenia (HP:0001913) | 1.98624249 |
| 79 | Pulmonary infiltrates (HP:0002113) | 1.95682299 |
| 80 | Gangrene (HP:0100758) | 1.89476291 |
| 81 | Autoimmune thrombocytopenia (HP:0001973) | 1.89196881 |
| 82 | Acute myeloid leukemia (HP:0004808) | 1.89183838 |
| 83 | Prominent nose (HP:0000448) | 1.87241961 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 1.87024632 |
| 85 | Urticaria (HP:0001025) | 1.86981899 |
| 86 | IgG deficiency (HP:0004315) | 1.86724207 |
| 87 | Abnormality of the columella (HP:0009929) | 1.86534442 |
| 88 | Acute hepatic failure (HP:0006554) | 1.85989552 |
| 89 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83440458 |
| 90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83440458 |
| 91 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83440458 |
| 92 | Orthostatic hypotension (HP:0001278) | 1.83023118 |
| 93 | Colitis (HP:0002583) | 1.79967547 |
| 94 | Chronic diarrhea (HP:0002028) | 1.79517757 |
| 95 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.79418421 |
| 96 | Abnormality of the sella turcica (HP:0002679) | 1.78162340 |
| 97 | Hematochezia (HP:0002573) | 1.78016337 |
| 98 | Dislocated radial head (HP:0003083) | 1.78003906 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 1.77891567 |
| 100 | Narrow palate (HP:0000189) | 1.77752159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.68111849 |
| 2 | BLK | 3.29377669 |
| 3 | FRK | 2.69739193 |
| 4 | MAP4K1 | 2.59384794 |
| 5 | TGFBR2 | 2.56701575 |
| 6 | TXK | 2.50315094 |
| 7 | MAP2K3 | 2.44287813 |
| 8 | GRK6 | 2.19735539 |
| 9 | MAP3K2 | 2.19102058 |
| 10 | GRK5 | 2.15298802 |
| 11 | ACVR1B | 2.09682656 |
| 12 | PIK3CG | 2.03848172 |
| 13 | BMPR2 | 2.02478134 |
| 14 | IRAK4 | 1.96134987 |
| 15 | TAOK3 | 1.95480996 |
| 16 | FGR | 1.95157064 |
| 17 | IKBKE | 1.90731401 |
| 18 | JAK3 | 1.88732093 |
| 19 | GRK7 | 1.88526068 |
| 20 | CSK | 1.84987630 |
| 21 | MAP3K6 | 1.78856995 |
| 22 | IRAK1 | 1.77271758 |
| 23 | SYK | 1.71257551 |
| 24 | AKT3 | 1.64461427 |
| 25 | IRAK2 | 1.60781165 |
| 26 | TYK2 | 1.51194333 |
| 27 | ZAP70 | 1.48294445 |
| 28 | STK10 | 1.48174590 |
| 29 | JAK1 | 1.39740710 |
| 30 | SGK2 | 1.39271596 |
| 31 | WNK1 | 1.39177600 |
| 32 | FGFR3 | 1.38614772 |
| 33 | TEC | 1.37650587 |
| 34 | FES | 1.37574382 |
| 35 | BTK | 1.34786210 |
| 36 | PTK2B | 1.29946898 |
| 37 | STK4 | 1.29892951 |
| 38 | MOS | 1.29639868 |
| 39 | JAK2 | 1.23230415 |
| 40 | MAP3K14 | 1.17151459 |
| 41 | HCK | 1.15161220 |
| 42 | CAMKK2 | 1.13136520 |
| 43 | ITK | 1.12182258 |
| 44 | PIM1 | 1.11337196 |
| 45 | MARK3 | 1.07761522 |
| 46 | YES1 | 1.01273138 |
| 47 | SGK3 | 1.01236622 |
| 48 | MAP2K4 | 1.00358120 |
| 49 | LYN | 0.99879219 |
| 50 | MAP3K1 | 0.99237114 |
| 51 | CDK12 | 0.99232209 |
| 52 | PKN2 | 0.95334951 |
| 53 | MARK2 | 0.94946103 |
| 54 | MELK | 0.94517854 |
| 55 | PDK1 | 0.93332874 |
| 56 | NLK | 0.91587549 |
| 57 | MAP3K5 | 0.90759840 |
| 58 | PLK2 | 0.89189884 |
| 59 | RET | 0.88930087 |
| 60 | PRPF4B | 0.88838424 |
| 61 | CSF1R | 0.88034934 |
| 62 | LCK | 0.87718941 |
| 63 | KSR1 | 0.86514249 |
| 64 | MATK | 0.85262784 |
| 65 | LRRK2 | 0.77690552 |
| 66 | CAMK4 | 0.76838753 |
| 67 | DYRK1A | 0.75587507 |
| 68 | ERBB2 | 0.74438301 |
| 69 | KSR2 | 0.74386657 |
| 70 | RAF1 | 0.72394164 |
| 71 | CAMK1G | 0.71697612 |
| 72 | CAMK1D | 0.71049655 |
| 73 | STK11 | 0.69421256 |
| 74 | MAP3K13 | 0.68691759 |
| 75 | ADRBK1 | 0.68343415 |
| 76 | SGK223 | 0.65838931 |
| 77 | SGK494 | 0.65838931 |
| 78 | EPHA3 | 0.62645881 |
| 79 | TRPM7 | 0.61515136 |
| 80 | SGK1 | 0.60778211 |
| 81 | MAP2K6 | 0.58731396 |
| 82 | MAP3K11 | 0.57144406 |
| 83 | STK38 | 0.54760423 |
| 84 | STK16 | 0.54752522 |
| 85 | PRKCQ | 0.54197869 |
| 86 | EPHB1 | 0.53167517 |
| 87 | TNK2 | 0.52154653 |
| 88 | MAP3K7 | 0.51238861 |
| 89 | IKBKB | 0.47443506 |
| 90 | KIT | 0.46633034 |
| 91 | CDK6 | 0.44828825 |
| 92 | EGFR | 0.43185451 |
| 93 | HIPK2 | 0.40636999 |
| 94 | TAOK1 | 0.40454282 |
| 95 | NEK6 | 0.40185552 |
| 96 | FGFR4 | 0.35795725 |
| 97 | MAPKAPK2 | 0.35474448 |
| 98 | CHUK | 0.35398913 |
| 99 | NTRK3 | 0.35179957 |
| 100 | NUAK1 | 0.34010508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.48914848 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45886761 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33640057 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.30900271 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.97345320 |
| 6 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.96688387 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96497437 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.92213521 |
| 9 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.90322384 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87198175 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77143242 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73207215 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.71232662 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.59355943 |
| 15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.59139083 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58350058 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55745753 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55202058 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55188705 |
| 20 | Platelet activation_Homo sapiens_hsa04611 | 1.54935386 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47111802 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45370384 |
| 23 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.44140118 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.38199979 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.36861082 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36580849 |
| 27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.36549191 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36034036 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34061364 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.30682808 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28896680 |
| 32 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.27118289 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.26484009 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26423042 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25620281 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.24886290 |
| 37 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.22874141 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21598141 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20529809 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18354907 |
| 41 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15956108 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12437954 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07378487 |
| 44 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05884423 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04632736 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01905113 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01461514 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.99799205 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99443978 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95312287 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.94860605 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93511542 |
| 53 | Prostate cancer_Homo sapiens_hsa05215 | 0.93139586 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91798647 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90599504 |
| 56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89534447 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89196224 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88488484 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.88074715 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.86363968 |
| 61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85880193 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84823196 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84644681 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.81803716 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78364805 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78061770 |
| 67 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77609790 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76901082 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76428042 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75159844 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73320718 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70514257 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69719247 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.69465234 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68898087 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68625946 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.66480737 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65992244 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65947378 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64624440 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64378572 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61309050 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.59801893 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59299458 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58426645 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58228643 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57323187 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55803364 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.52858926 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.50681869 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50164163 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49191684 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.49103927 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49014317 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46401815 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46236897 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44442524 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42067908 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.41927705 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41392331 |

